← Back to Clinical Trials
Recruiting NCT05995886

NCT05995886 Using Facebook to Support Opioid Recovery Among American Indian Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05995886
Status Recruiting
Phase
Sponsor Mayo Clinic
Condition Opioid Use Disorder
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2023-10-16
Primary Completion 2026-10-12

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Wiidookaage'win Facebook Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2023-10-16 with a primary completion date of 2026-10-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to find out whether a Facebook group will help Native women in recovery from opioid use.

Eligibility Criteria

Inclusion Criteria: 1. AIAN person based on self-reported race/ethnicity 2. Gender identity as a woman 3. At least 18 years of age with no upper age limit 4. Resides in Minnesota 5. Meets criteria for OUD based on the DSM-5 Checklist (American Psychiatric Association, 2013) 6. Self-reports at least one month of abstinence from opioid use based on TLFB interview and negative urine opiate screen 7. Current use of MOUD 8. Is comfortable speaking and reading English 9. Has an existing Facebook account or willing to set one up 10. Is willing and able to participate in the Facebook intervention for 3 months 11. Has access to broadband internet on a mobile phone/computer/tablet at any location 12. Is willing and able to travel to a community clinic in Minneapolis, Minnesota for the UDS or is willing to and able to complete a virtual Zoom UDS visit. 13. Provides written informed consent Exclusion Criteria: 1. Self-reports current suicidality based on the Concise Heath Risk Tracking scale 2. Participated in prior study phases (Aim 1 formative work) of NIDA CTN-0123

Contact & Investigator

Central Contact

Ashley Brown

✉ wiidookaagewin@mayo.edu

📞 1-833-880-2600

Principal Investigator

Christi A Patten, PhD

PRINCIPAL INVESTIGATOR

Mayo Clinic

Frequently Asked Questions

Who can join the NCT05995886 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Opioid Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05995886 currently recruiting?

Yes, NCT05995886 is actively recruiting participants. Contact the research team at wiidookaagewin@mayo.edu for enrollment information.

Where is the NCT05995886 trial being conducted?

This trial is being conducted at Rochester, United States.

Who is sponsoring the NCT05995886 clinical trial?

NCT05995886 is sponsored by Mayo Clinic. The principal investigator is Christi A Patten, PhD at Mayo Clinic. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology